Biomedical Research Institute, Pusan National University Hospital, Busan, 49241, Republic of Korea.
Gimhae Biomedical Center, Gyeongnam, 621-842, Republic of Korea.
Int J Pharm. 2017 Oct 30;532(1):194-203. doi: 10.1016/j.ijpharm.2017.08.128. Epub 2017 Sep 6.
The polysaccharide chitosan has abundant cationic amine groups, and can form ion-complexes with anionic molecules such as the strong photosensitizer chlorin e6 (Ce6). In this study, water-soluble chitosan (WSC) was used to fabricate Ce6-incorporated nanophotosensitizers (Abbreviated as ChitoCe6 nanophotosensitizer) via a self-assembling process. This was accomplished by dissolving WSC in pure water and then directly mixing the solution with solid Ce6 causing ion complex formation between WSC and Ce6. The resulting nanophotosensitizer was spherical in shape and had a particle size of less than 300nm. The photodynamic effect of ChitoCe6 nanophotosensitizer was evaluated using gastrointestinal (GI) cancer cells. At in vitro study using SNU478 cholangiocarcinoma cells, ChitoCe6 nanophotosensitizer showed improved Ce6 uptake by tumor cells, reactive oxygen species production, and cellular phototoxicity. An in vivo study using SNU478-bearing nude mice showed that the ChitoCe6 nanophotosensitizer efficiently accumulated in the tumor tissue and inhibited tumor growth more than treatment with Ce6 alone. Furthermore, ChitoCe6 nanophotosensitizer was also efficiently absorbed through tissue layers in an ex vivo study using porcine bile duct explants. ChitoCe6 nanophotosensitizer showed enhanced photosensitivity and photodynamic effects against cancer cells in vitro and in vivo. We present ChitoCe6 nanophotosensitizer as a promising candidate for photodynamic therapy of GI cancer.
壳聚糖具有丰富的阳离子胺基,可以与阴离子分子(如强光敏剂氯乙酮(Ce6))形成离子复合物。在本研究中,通过自组装过程,使用水溶性壳聚糖(WSC)制备了包含 Ce6 的纳米光敏剂(简称 ChitoCe6 纳米光敏剂)。这是通过将 WSC 溶解在纯水中,然后直接将溶液与固体 Ce6 混合来实现的,这导致了 WSC 和 Ce6 之间的离子复合物形成。所得纳米光敏剂呈球形,粒径小于 300nm。通过胃肠道(GI)癌细胞评估了 ChitoCe6 纳米光敏剂的光动力效应。在使用 SNU478 胆管癌细胞的体外研究中,ChitoCe6 纳米光敏剂显示出改善的 Ce6 摄取、活性氧物质产生和细胞光毒性。在使用 SNU478 荷瘤裸鼠的体内研究中,ChitoCe6 纳米光敏剂能够有效地在肿瘤组织中积累,并比单独使用 Ce6 更有效地抑制肿瘤生长。此外,在使用猪胆管外植体的离体研究中,ChitoCe6 纳米光敏剂也能够有效地被组织层吸收。ChitoCe6 纳米光敏剂在体外和体内对癌细胞表现出增强的光敏性和光动力效应。我们提出 ChitoCe6 纳米光敏剂作为 GI 癌症光动力治疗的有前途的候选物。